The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Related articles in The JI
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
The Journal of Immunology, 2003, 170: 4423-4424.
Copyright © 2003 by The American Association of Immunologists

IN THIS ISSUE

In the groove


Movement of the MHC class II (MHC II) molecule from the endoplasmic reticulum is facilitated by its association with the MHC II-associated invariant chain (Ii). Although most of the Ii molecule is removed by proteolysis in the endosomes, a small fragment called CLIP (class II-associated Ii peptide) remains in the MHC II peptide binding groove. The release of CLIP, required to permit loading of antigenic peptides, is accelerated by an endosomal peptide exchange factor, HLA-DM. Doebele et al. (p. 4683 ) used mutational and biochemical analyses to map MHC II-CLIP contact sites in DR3. They generated a series of DR3 mutants that mapped to the P4 and P6 pockets in the peptide-binding groove. Several of those mutants showed increased accumulation of CLIP in cells and increased stability of solubilized mutant DR/CLIP complexes in the presence of SDS. In vitro release of biotinylated CLIP from purified mutant DR3 molecules was slower than from wild-type DR3 molecules in the presence and absence of soluble HLA-DM. The results suggest that there are constraints on natural MHC II polymorphism to prevent high-affinity MHC II-CLIP interactions that would block MHC II loading of antigenic peptides.

CD4+ T cells and autoimmune hepatitis

Although liver biopsies from patients suffering from autoimmune hepatitis contain large numbers of CD4+ T cells, the role of those cells in the disease is unclear. Gorham et al. previously used a BALB/c mouse model to show that the cytokine TGF-{beta}1 protects against necroinflammatory liver disease. In a continuation of those studies, Rudner et al. (p. 4785 ) demonstrated that mice deficient in TGF-{beta}1 had an increase in T cells and macrophages in their livers and died before 18 days of age. An anti-CD3 redirected lysis assay showed high levels of hepatic T cell cytolytic activity. Mice doubly deficient in TGF-{beta}1 and RAG-1, and therefore lacking mature B and/or T cells, had prolonged survival and failed to develop autoimmune hepatitis. Ab-mediated depletion of CD4+ T cells in young BALB/c-TFG-{beta}1-/- mice prevented liver damage, thus implicating CD4+ T cells in the disease process. The exact mechanism by which CD4+ T cells engineer the death of the hepatocytes is unknown. However, the ability of TGF-{beta}1 to inhibit cytolytic T cells may be useful in exploring normal liver immune function and in understanding liver pathologies such as infections, tumor growth, and drug toxicity.

Lymphoid neogenesis

Naive T cells enter into nonlymphoid tissues in several conditions, including autoimmune diseases, and form tertiary lymphoid tissue in a process called lymphoid neogenesis. Chemokines such as CCR7 ligands have been implicated in the process. Weninger et al. (p. 4638 ) superfused the cremaster muscles of T-GFP mice with the CCR7 ligand, CCL21, and used intravital microscopy to detect the sticking of green fluorescent protein-expressing naive (CD44low) T cells to the microvasculature. The primary adhesion molecule was LFA-1, as prior injection of the cremaster muscle with anti-LFA-1 blocking mAb abolished T cell adherence. Positive immunohistochemical detection of CCL21 in blood vessels and in situ hybridization of CCL21 mRNA in vascular endothelial cells was seen in samples from patients with ulcerative colitis and rheumatoid arthritis, but not with psoriasis. Naive T cells were detected in the ulcerative colitis and rheumatoid arthritis tissues but rarely in psoriasis tissues. The authors suggest that endothelial cell presentation of CCL21 triggers an influx of naive T cells into tertiary tissues, a process that may be targeted for disruption in treating chronic inflammation.

CD1-Ag interactions: low affinity but stable


CD1 molecules and their associated {beta}2-microglobulins function similarly to MHC in presenting Ags to {alpha}{beta} TCRs. However, CD1 presents lipids and glycolipids rather than peptides. Published functional assays measured the half-life of the binding interaction of a glycolipid, {alpha}-galactosylceramide ({alpha}GC), with mouse CD1d at ~1 day, whereas biophysical measurements using surface plasmon resonance (SPR) reported interactions of less than 1 min. Cantu et al. (p. 4673 ) evaluated SPR against several new biochemical and biophysical methods they developed to resolve the discrepancies in the published reports. The authors determined that recombinant soluble CD1d interacted nonspecifically with hydrophobic surfaces in SPR experiments. Isoelectric focusing binding assays and thermal titration calorimetry experiments showed that CD1d bound lipids with low affinity but that the dissociation of the resulting CD1d-lipid complexes took more than 1 day. Temperature and ionic strength did not affect the interactions. The CD1d-{alpha}GC complex was recognized by the TCR of NK T cells. Pairing of the V{alpha}14 chain of the TCR with a variety of {beta}-chains in soluble complexes did not alter binding with the CD1d-{alpha}GC complex. The thermodynamics of the CD1d/{alpha}GC-V{alpha}14 TCR interactions suggested that the rigid structure of the lipid sugar moiety was the most important part of the ligand seen by the TCR.

Cytokines and Th2 differentiation

Dendritic cells (DC) orchestrate Th1/Th2 subset differentiation of CD4+ Th cells. Two factors that determine the path of differentiation are expression of DC surface markers and secretion of specific cytokines by DC. Dodge et al. (p. 4457 ) examined DC from lung and spleen and found that the lung population was CD8{alpha}- and contained a subpopulation of cells expressing high levels of CD11b. LPS-stimulated pulmonary DC secreted higher levels of IL-6 and much lower levels of IL-12 than spleen DC. LPS-stimulated pulmonary DC from IL-6-/- mice produced elevated levels of IL-12 and induced a strong Th1 response in naive CD4+ T cells. Pulmonary DC cocultured with naive CD4+ T cells in the presence of anti-IL-6 neutralizing Ab had increased IFN-{gamma} levels, decreased IL-4 levels, and Th1 polarization. These results indicate that the high levels of IL-6 produced by pulmonary DC inhibit secretion of IL-12, thus diminishing Th1-mediated chronic inflammatory responses in the lung.

Less fas


The cyclopentenone-type prostaglandin, 15-deoxy-{Delta}12,14-PGJ2 (15d-PGJ2), is an anti-inflammatory molecule produced by immune and other cells. In an attempt to understand the mechanism of 15d-PGJ2 action on Fas-FasL-mediated apoptosis, Cippitelli et al. (p. 4578 ) analyzed fas-L mRNA expression in activated T cells in the absence and presence of 15d-PGJ2. 15d-PGJ2 significantly decreased activation-induced cell death and decreased fas-L mRNA expression through direct interaction with the fas-L promoter as determined by luciferase reporter assays. The interaction was independent of PPAR{gamma} coexpression. 15d-PGJ2 decreased the activity and expression of transcription factors EGR-3, NF-{kappa}B, cMyc, and AP-1 and increased the activity and expression of EGR-1 and Nur77. The reactive portion of 15d-PGJ2 was found to reside in the cyclopentenone ring. The complex effects of 15d-PGJ2 on the transcriptional activity of molecules, especially fas-L, involved in the inflammatory process suggest that 15d-PGJ2 could be a useful therapeutic agent to control autoimmune and inflammatory disorders.

Two pathways to lupus nephritis?

The degree of lupus nephritis that accompanies human systemic lupus erythematosus (SLE) can range from severe inflammation to glomerulosclerosis and renal failure. The mechanisms responsible for the different patterns of nephritis are not understood. Singh et al. (p. 4818 ) studied two mouse models of SLE, the New Zealand Mixed (NZM.2410) strain, which develops severe glomerulosclerosis, and the MRL-lpr strain, which develops severe kidney inflammation. Using a sensitive in vivo cytokine capture assay, the authors showed that compared with nonautoimmune mouse strains, NZM.2410 mice overproduced the type 2 cytokine, IL-4, whereas MLR-lpr mice overproduced the type 1 cytokine, IFN-{gamma}. Anti-IL-4 mAb treatment of NZM.2410 mice decreased the incidence of glomerulosclerosis as did a STAT6 null mutation, implicating IL-4 and STAT6 in the severe inflammation. NZM.2410 mice deficient in STAT4 had an increase in kidney disease but lower levels of IgG autoantibodies, suggesting a major role for type 1 cytokines in the production of anti-dsDNA Abs. If the delineation of two specific subsets of nephritis, characterized by different cytokine and STAT protein contributions, holds up for human patients, it may be possible to tailor therapy to distinct manifestations of kidney disease in SLE.

Along for the ride


Synovial fibroblasts (SFs) of patients with rheumatoid arthritis (RA) and tumor cells are similar in that both have a high rate of metabolic activity that is supported in part by an increased uptake and catabolism of albumin. Building on the current phase II clinical trials of human serum albumin as a carrier of methotrexate (MTX-HSA) to treat human tumors, Wunder et al. (p. 4793 ) examined the suitability of MTX-HSA for treatment of RA. The authors found that fluorescence labeled HSA (AFLc-HSA) localized to the inflamed paws of mice with collagen-induced arthritis within 3 h of i.v. injection. AFLc-HSA accumulated in the cytoplasm of SFs from a patient with RA that had been implanted subcutaneously in SCID mice i.v. injected with the labeled albumin. Colocalization of the AFLc-HSA and acridine orange in the cytoplasm of in vitro cultured SFs indicated that the albumin was metabolized in lysosomes. Treatment of mice before the onset of collagen-induced arthritis demonstrated that equivalent reductions in the incidence of arthritis were obtained with a dose of MTX-HSA only one-fifth that of uncoupled MTX. The results suggest that MTX-HSA could be an effective treatment for RA, resulting in increased delivery of low doses of MTX specifically to affected joints.

BCR signaling and autoimmunity


To assess genetic factors involved in the pathogenesis of systemic lupus erythematosus (SLE), Wang et al. (p. 4826 ) explored differences in the B cell responses of DBA/2 and BALB/c mice immunized with a peptide mimetope of DNA (MAP-peptide). Immunization with MAP peptide resulted in a lower frequency of Ab-secreting B cells in the naive B cell repertoire in the DBA/2 mice compared with the BALB/c mice, and this frequency was not increased by LPS stimulation. Treatment of purified B cells from DBA/2 mice with biotinylated anti-IgM Ab induced greater BCR-mediated apoptosis and calcium signaling than in B cells from BALB/c mice. The greater susceptibility of DBA/2 B cells to negative selection following antigenic stimulation appeared to protect against the development of autoimmunity, suggesting a possible new approach to the treatment of SLE.

Summaries written by Dorothy L. Buchhagen, Ph.D.


Related articles in The JI:

IL-6 Production by Pulmonary Dendritic Cells Impedes Th1 Immune Responses
Ingrid L. Dodge, Michelle Woldemar Carr, Manuela Cernadas, and Michael B. Brenner
The JI 2003 170: 4457-4464. [Abstract] [Full Text]  

The Cyclopentenone-Type Prostaglandin 15-Deoxy-{Delta}12,14-Prostaglandin J2 Inhibits CD95 Ligand Gene Expression in T Lymphocytes: Interference with Promoter Activation Via Peroxisome Proliferator-Activated Receptor-{gamma}-Independent Mechanisms
Marco Cippitelli, Cinzia Fionda, Danilo Di Bona, Aldo Lupo, Mario Piccoli, Luigi Frati, and Angela Santoni
The JI 2003 170: 4578-4592. [Abstract] [Full Text]  

Naive T Cell Recruitment to Nonlymphoid Tissues: A Role for Endothelium-Expressed CC Chemokine Ligand 21 in Autoimmune Disease and Lymphoid Neogenesis
Wolfgang Weninger, Hege S. Carlsen, Mahmoud Goodarzi, Farzad Moazed, Maura A. Crowley, Espen S. Baekkevold, Lois L. Cavanagh, and Ulrich H. von Andrian
The JI 2003 170: 4638-4648. [Abstract] [Full Text]  

The Paradox of Immune Molecular Recognition of {alpha}-Galactosylceramide: Low Affinity, Low Specificity for CD1d, High Affinity for {alpha}{beta} TCRs
Carlos Cantu, III, Kamel Benlagha, Paul B. Savage, Albert Bendelac, and Luc Teyton
The JI 2003 170: 4673-4682. [Abstract] [Full Text]  

Point Mutations in or Near the Antigen-Binding Groove of HLA-DR3 Implicate Class II-Associated Invariant Chain Peptide Affinity as a Constraint on MHC Class II Polymorphism
Robert C. Doebele, Achal Pashine, Wendy Liu, Dennis M. Zaller, Michael Belmares, Robert Busch, and Elizabeth D. Mellins
The JI 2003 170: 4683-4692. [Abstract] [Full Text]  

Necroinflammatory Liver Disease in BALB/c Background, TGF-{beta}1-Deficient Mice Requires CD4+ T Cells
Lynnie A. Rudner, Jack T. Lin, Il-Kyoo Park, Justin M. M. Cates, Darci A. Dyer, Douglas M. Franz, Margaret A. French, Elizabeth M. Duncan, Hillary D. White, and James D. Gorham
The JI 2003 170: 4785-4792. [Abstract] [Full Text]  

Albumin-Based Drug Delivery as Novel Therapeutic Approach for Rheumatoid Arthritis
Andreas Wunder, Ulf Müller-Ladner, Ernst H. K. Stelzer, Jürgen Funk, Elena Neumann, Gerd Stehle, Thomas Pap, Hannsjörg Sinn, Steffen Gay, and Christoph Fiehn
The JI 2003 170: 4793-4801. [Abstract] [Full Text]  

Differential Contribution of IL-4 and STAT6 vs STAT4 to the Development of Lupus Nephritis
Ram Raj Singh, Vijay Saxena, Song Zang, Lily Li, Fred D. Finkelman, David P. Witte, and Chaim O. Jacob
The JI 2003 170: 4818-4825. [Abstract] [Full Text]  

The Naive B Cell Repertoire Predisposes to Antigen-Induced Systemic Lupus Erythematosus
Chuansheng Wang, Magi Khalil, Jeffrey Ravetch, and Betty Diamond
The JI 2003 170: 4826-4832. [Abstract] [Full Text]  




This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Related articles in The JI
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS